Sun Pharmaceutical (SUNPHARMA) — Sustainability Report

Sun Pharmaceutical announced the appointment of Aalok Shanghvi as Chief Operating Officer effective immediately, elevating him from Whole-time Director and Executive Vice-President of Emerging Markets, Global Generic R&D, Business Development, Operations and API. The filing underscores leadership continuity as Shanghvi oversees 18% of global revenue and has served as Whole-time Director since June 2023.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,50,643.09 Cr P/E: 41.3 ROE: 15.1% ROCE: 20.3%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How does this sustainability report affect Sun Pharmaceutical Industries Limited's outlook?" "What did Sun Pharmaceutical Industries Limited announce on 3 February 2025?" "Is this positive or negative for SUNPHARMA?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 3 February 2025

SBIN State Bank of India Financial Results TATACONSUM TATA CONSUMER PRODUCTS LIMITED Financial Results VBL Varun Beverages Limited Financial Results BAJFINANCE Bajaj Finance Limited Financial Results BEL Bharat Electronics Limited Financial Results SBICARD SBI Cards and Payment Services Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.